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A B S T R A C T
The 5-lipoxygenase-associated cascade has appeared as potential therapeutic target in attenuating inflammatory
pathologies. Progression and pathophysiology of inflammation have also shown potential involvement of oxi-
dative stress and inflammatory pathways. Three drimane sesquiterpene quinols, characterised as 3-(hept-36-
enyloxy)-decahydro-4,6a,12a,12b-tetramethyl-1H-benzo[a]xanthene-4,10,12-triol (1), 13-[[2-(hexyloxy)-
2,5,5,8a-tetramethyldecahydro-1-naphthalenyl](methoxy)methyl]benzenol (2), and 1-butoxy-4,4,11b,11c-tet-
ramethyl-decahydrobenzo[kl]xanthen-10-ol (3) were purified from the organic extract of intertidal marine
macroalga Gracilaria salicornia, obtained from the southeast coastal regions of Indian peninsular. The 1H-benzo
[a]xanthene-triol derivative (1) registered potential activities against pro-inflammatory 5-lipoxygenase (IC50
1.7mM) and free radicals (IC50 1.3–1.6mM). The in silico molecular modelling studies to designate 5-lipox-
ygenase inhibitory mechanism of the studied analogues and the comparison of docking parameters attributed
that the drimane sesquiterpene 1 exhibited least binding energy of −12.30 kcal mol−1, and showed effective
hydrogen bonding interactions with the catalytic site of the enzyme. The higher electronic parameters and
permissible hydrophobic-hydrophilic balance of the drimane sesquiterpene bearing 1H-benzo[a]xanthene-triol
moiety (1) appeared to constitute significant roles towards the attenuation of pro-inflammatory 5-lipoxygenase.
Putative biosynthetic pathway of the studied compounds involving cyclisation of farnesyl diphosphate and
carbocationic rearrangement through a battery of enzyme-mediated cascade validated their structural attribu-
tions. These results demonstrated that the drimane-type sesquiterpenoids with 1H-benzo[a]xanthene-triol fra-
mework could be used as a potential therapeutic agent for the treatment of 5-lipoxygenase-mediated in-
flammatory pathologies.
1. Introduction
Marine macroalgae (otherwise named as seaweeds) are recognised
resources of potential therapeutic agents, which could be used in var-
ious health disorders [1]. Among various macroalgae, the genus Gra-
cilaria has been extensively studied for the presence of various bioactive
metabolites with antioxidant and anti-inflammatory potentials, and has
been regarded as one of the economically valuable resources [2–3],
even though, the complete chemistries of these particular species were
not fully explored. Marine red macroalgae (phylum Rhodophyta) were
found to be the important sources of pharmacologically active sesqui-
terpenes, and these algae received greater attention due to their cap-
ability to biosynthesise structurally diverse skeletons of sesquiterpenes,
such as sesquiterpenoid quinols [4–5].
Several drug discovery and development programs are focused on
the search for anti-inflammatory bioactive compounds obtained from
the marine natural sources. The inflammatory response is a highly
regulated process, and its dysregulation could lead to the establishment
of chronic inflammations, wherein the arachidonic acid pathway
overproduces pro-inflammatory eicosanoids [6]. The 5-lipoxygenase (5-
LOX) is one of the two major enzymes (the other being cyclooxygenase-
2, COX-2) families catalyzing the rate-limiting step in the formation of
inflammatory leukotrienes, and these products are significant mediators
of inflammatory pathologies [7]. Selective 5-LOX inhibitors received
greater attention in recent years. It is of note that the simultaneous
inhibition of COX-2/5-LOX is important to allow the synthesis of li-
poxins to resolve inflammation and attenuate residual leukotriene ef-
fects [7]. It is, therefore, necessary to find suitable therapeutics that
https://doi.org/10.1016/j.algal.2019.101472
Received 9 October 2018; Received in revised form 1 February 2019; Accepted 12 March 2019
⁎ Corresponding author.
E-mail address: kajal.chakraborty@icar.gov.in (K. Chakraborty).
1 Equal contribution.
2 Department of Chemistry, Mangalore University, Mangalagangothri- 574,199, Karnataka State, India.
Algal Research 39 (2019) 101472
2211-9264/ © 2019 Published by Elsevier B.V.
T
could selectively inhibit 5-LOX and COX-2 simultaneously while
maintaining the ratio of COX-1/COX-2 below the threshold range
(lesser than 1.0) for targeted and selective activities against in-
flammatory responses. The up-regulation of pro-inflammatory enzymes
in the inflammatory cascade has been related to the generation of cel-
lular reactive free radicals, and therefore, attempts are underway to
develop pharmacophore leads possessing antioxidant and anti-in-
flammatory activities.
The marine macroalgae of genus Gracilaria sp. are abundantly available
in the coastal peninsular India with>300 reported species, and were re-
cognised in industrial algal biotechnology due to the commercial product
phycocolloid, which was widely used in food, pharmaceutical and cosmetic
industries [2,8–9]. Among different species of the genus Gracilaria, Gracilaria
salicornia (C. Agardh) E.Y. Dawson was found to be ubiquitous in the coastal
waters of Indian peninsular, although this species was not extensively in-
vestigated to characterise the bioactive leads. The present work described the
purification and characterisation of three previously unreported drimane-
associated quinols from the organic solvent extract of G. salicornia collected
from the southeast coastal regions of Indian peninsular. The studied com-
pounds, which were designated as 3-(hept-36-enyloxy)-decahydro-
4,6a,12a,12b-tetramethyl-1H-benzo[a]xanthene-4,10,12-triol (1), 13-[
[2-(hexyloxy)-2,5,5,8a-tetramethyldecahydro-1-naphthalenyl](methoxy)me-
thyl]benzenol (2), and 1-butoxy-4,4,11b,11c-tetramethyl-decahydrobenzo
[kl]xanthen-10-ol (3) (Fig. 1), were characterised by extensive spectroscopic
experiments. The pharmacological activities were assessed by different se-
lective in vitro anti-inflammatory and antioxidant assays. The physicochem-
ical parameters of these compounds were utilised to corroborate their
structural features with their bioactive potentials. An enzyme-mediated
biosynthetic cascade leading to the formation of drimane sesquiterpenoid
quinol derivatives was proposed. The in silico mode of 5-LOX enzyme in-
hibition by the studied compounds was assessed by the molecular docking
models to correlate with their in vitro anti-inflammatory potential.
2. Experimental
2.1. General experimental procedures
Fourier-transform-infrared (FT-IR) absorption spectra of the studied
metabolites were documented between the wave numbers
4000–400 cm−1 using pellets of KBR on a Perkin-Elmer Series 2000 FT-
IR spectrometer. A Varian-Cary 50 UV/VIS (ultra-violet) spectro-
photometer (Varian Cary, USA) was used for UV-spectral analysis. The
spectroscopic analysis including one-dimensional (1D) {1H (proton)-
500MHz, 13C (carbon)-125MHz, DEPT135 (distortionless enhancement
by polarization transfer)} and two-dimensional (2D) {1H–1H COSY
(correlation spectroscopy), HSQC (heteronuclear single quantum co-
herence), HMBC (heteronuclear multiple bond correlation), NOESY
(nuclear overhauser effect spectroscopy)} NMR were documented by
Bruker Avance DPX 500 (500MHz) spectrometer using deuterated
chloroform (CDCl3) [10]. A gas chromatograph-mass spectrometer
(GC–MS) operating with the electron-impact (EI) mode (Varian GC
model, CP-3800 housed in a mass spectrometer model Varian 1200 L)
was used for the mass spectral analysis. The HPLC (high pressure liquid
chromatography) analysis was conducted by using a reverse phase C18
column (RP-C18) (Luna, 250mm×4.6mm, 5 μm, Phenomenex, Tor-
rance, CA), and the traces were identified with an diode-array detector
(DAD) (SPD M20A, Kyoto, Japan). A rotary vacuum evaporating in-
strument (IKA Werke GmbH & Co., Germany) was used for removal of
the solvents. The flash chromatography instrument (Biotage AB SP1-
B1A, Sweden) mounting a silica-column (230–400 mesh, 12 g) was used
for the downstream purification. Thin-layer-chromatography (TLC)
experiments were conducted over silica gel plates (Merck, Kieselgel-
60F254). All analytical and spectroscopic grade reagents and solvents
were procured from E-Merck (Darmstadt, Germany) and Sigma Aldrich
Chemical Co. Inc. (Missouri, USA).
2.2. Preparation of organic solvent extracts from the algal materials
The thalli (leafy structures) of marine macroalga G. salicornia were
obtained from the Mandapam region (Gulf of Mannar, situated between
8°48′ N, 78°9′ E and 9°14′ N, 79°14′ E) along the southeast coastal areas
of India. The marine macroalgal samples (voucher specimen number
AC.3.1.1.4) were subjected to repeated washing with running water
before being dried at room temperature for 3–4 days. Dried marine
macroalgae were ground (1×103 g), and extracted with equipropor-
tional volume (1:1 v/v, 500mL) of ethyl acetate (EtOAc) and methanol
Fig. 1. Structural representations of (A) 3-(hept-36-enyloxy)-decahydro-4,6a,12a,12b-tetramethyl-1H-benzo[a]xanthene-4,10,12-triol (compound 1), (B) 13-[[2-
(hexyloxy)-2,5,5,8a-tetramethyldecahydro-1-naphthalenyl](methoxy)methyl]benzenol (compound 2), and (C) 1-butoxy-4,4,11b,11c-tetramethyl-decahydrobenzo
[kl]xanthen-10-ol (compound 3) isolated from red marine macroalga G. salicornia. (D) The representative photograph of thalli (leaf-like structures) of G. salicornia.
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(MeOH) at 55–60 °C for 4 h. The extracts were filtered through
Whatman No. 1 filter paper using anhydrous sodium sulfate (Na2SO4,
100 g) to remove traces of water from the organic solvent extract. The
filtered residues were used for repeated EtOAc:MeOH solvent extraction
to obtain maximum yield of the organic solvent extract. The combined
organic solvent extract was concentrated initially by using a rotary
vacuum evaporator (IKA Werke GmbH & Co., Germany) at 50 °C to
reduce the organic solvent to its one-third volume and later by a rotary
vacuum concentrator (RVC-2-33IR, Martin Christ Gefriertrock-
nungsanlagen GmbH, Germany) to obtain the dried crude organic sol-
vent extract (35 g) of G. salicornia [10]. The crude extract of G. sali-
cornia was subjected for chromatographic fractionation by using var-
ious chromatographic techniques.
2.3. Chromatographic fractionation
The organic solvent extract of G. salicornia (33 g) was fractionated
by chromatographic separation techniques. Initially, the slurry of the
organic solvent extract was made with silica gel of mesh size 60–120
(4 g), and it was packed to an open glass column (1m×0.04m) filled
with silica of mesh sized 60–120 (450 g) for purification. The separation
of compounds were carried out with solvents of increasing polarity (n-
hexane/EtOAc to MeOH) to collect a total of 45 main fractions (10mL
each). These fractions were put together to eleven sub-column frac-
tions, which were referred to TA1 - TA11 after TLC (n-hexane:EtOAc,
9:1 v/v) along with RP C18-HPLC (MeOH/actonitrile-MeCN, 2:1 v/v)
experiments. The pooled homogeneous fractions were assessed for their
bioactive potencies, and the fractions with greater bioactive potential
were subjected to further downstream purification. The column sub-
fraction, TA3 (eluted after EtOAc:n-hexane 1:4 v/v; 8.1 g, 23% yield w/
w) displayed potential free radical (DPPH and ABTS+) scavenging
property, and thus, subjected to further chromatographic separations.
Therefore, TA3 was fractionated over an open column (45 cm×3 cm)
filled with 230–400 meshed silica using the solvent elution gradient of
n-hexane/EtOAc (49:1 to 3:2, v/v) to yield 15 sub-fractions (30mL
each). The latter sub-fractions were pooled to 6 fractions (TA3-1 through
TA3-6) on the basis of TLC (n-hexane:EtOAc, 8:2 v/v) as well as RP-C18
HPLC (3:2 MeOH/MeCN v/v) analyses. The sub-column fraction, TA3-1
(1.22 g), which was eluted after n-hexane:EtOAc (9:1, v/v) revealed
potential radical (DPPH) scavenging activity. Therefore, TA3–1 was
further subjected to flash-fractionation on silica gel (SP1-B1A, 230–400
mesh, 12 g; Biotage, Sweden) using n-hexane/EtOAc and MeOH
Table 1
NMR spectroscopic data of compounds (1–3) isolated from red seaweed G. salicornia.
1 2 3
C. no. 13C NMR 1H NMR H. int., mult., J in Hza C. no. 13C NMR 1H NMR H. int., mult., J in Hza C. no. 13C NMR 1H NMR H. int., mult., J in Hza
1 37.0 1.43 1H, t, J=12.0 Hz 1 65.7 1.92 1H, d, J=8.0 Hz 1 78.1 3.88 1H, t, J=9.2 Hz
1.23 1H, t, J=12.1 Hz 2 72.4 – – 2 29.6 1.81 1H, m
2 24.7 1.96 1H, m 3 39.3 1.77 1H, m 1.60 1H, m
1.56 1H, m 1.56 1H, m 3 22.7 1.57 1H, m
3 84.6 2.80 1H, t, J=9.8 Hz 4 19.6 1.62 1H, m 1.31 1H, m
– – 1.42 1H, m 3a 52.3 1.21 1H, dd, J=1.9, 12.1 Hz
4 73.9 – – 4a 55.0 0.88 1H, dd, J=1.8, 12.2 Hz 4 37.2 – –
4a 58.7 1.53 1H, dd, J=1.5, 12.1 Hz 5 32.7 – – 5 42.2 1.20 1H, td, J=13.2, 4.1 Hz
5 21.7 1.73 1H, m 6 45.0 1.50 1H, td, J=13.5, 4.1 Hz 1.51 1H, td, J=13.2, 4.3 Hz
1.45 1H, m 1.17 1H, td, J=12.9, 4.2 Hz 6 24.4 1.84 1H, t, J=12.7 Hz
6 33.4 1.70 1H, td, J=12.5, 3.4 Hz 7 19.3 1.75 1H, m 1.70 1H, t, J=12.9, 4.2 Hz
1.37 1H, td, J=12.5, 3.0 Hz 1.07 1H, m 6a 81.0 3.20 1H, t, J=9.2 Hz
6a 81.6 – – 8 39.4 1.51 1H, t, J=12.0 Hz 7a 139.9 – –
7a 146.5 – – 1.12 1H, t, J=12.0 Hz 8 118.1 6.26 1H, d, J=13.1 Hz
8 119.0 6.81 1H, d, J=13.4 Hz 8a 37.2 – – 9 121.7 6.20 1H, d, J=13.2 Hz
9 119.1 6.61 1H, d, J=13.8 Hz 9 22.5 1.22 3H, s 10 155.9 – –
10 140.9 – – 10 29.7 1.03 3H, s 11 115.1 6.31 1H, s
11 115.2 6.51 1H, s 11 29.3 1.00 3H, s 11a 128.7 – –
11a 126.3 – – 12 16.3 1.02 3H, s 11b 45.4 – –
12 65.5 4.68 1H, s 13 82.7 4.39 1H, d, J=8.2 Hz 11c 39.3 – –
12a 51.0 – – 131 58.9 3.37 3H, s 12 28.8 1.00 3H, s
12b 42.8 – – 1′ 154.3 – – 13 29.3 0.98 3H, s
13 22.6 1.15 3H, s 2′ 113.0 6.28 1H, s 14 22.6 1.37 3H, s
14 23.9 1.42 3H, s 3′ 144.0 – – 15 12.8 1.15 3H, s
15 14.1 0.88 3H, s 4′ 123.7 6.35 1H, d, J=12.1 Hz 11 74.6 3.44 2H, t, J=9.8 Hz
16 19.6 0.83 3H, s 5′ 128.4 7.08 1H, t, J=13.2 Hz 12 31.9 1.50 2H, m
31 71.1 3.69 2H, t, J=8.6 Hz 6′ 113.1 6.23 1H, d, J=13.1 Hz 13 18.7 1.43 2H, m
32 31.9 1.55 2H, m 21 65.0 3.69 2H, m 14 14.1 0.88 3H, t, J=6.8 Hz
33 26.7 1.21 2H, m 22 31.9 1.53 2H, m – – – –
34 29.6 1.33 2H, m 23 25.6 1.31 2H, m
35 33.8 2.04 2H, m 24 33.7 1.34 2H, m – – – –
36 139.2 5.82 1H, m 25 22.7 1.33 2H, m – – – –
37 114.0 5.01 1H, dd, J=3.4, 16.7 Hz 26 14.1 0.94 3H, t, J=6.7 Hz – – – –
4.94 1H, dd, J=3.4, 12.2 Hz – – – – – – – –
The assignments were made with the aid of the COSY, HSQC, HMΒC and NOESY experiments.
a Values in ppm, multiplicity and coupling constants (J=Hz) were indicated in parentheses. Multiplicities were allocated by DEPT135 NMR spectra.
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gradient to acquire 15 fractions (8mL each), which were put together to
TA3-1-1 to TA3-1-3 based on TLC (n-hexane:EtOAc, 9:1 v/v) and RP-C18
HPLC (MeOH/MeCN, 3:2 v/v) experiments. The column-fraction, TA3-1-
2 was subjected to preparatory HPLC (by using the solvent gradient of
MeOH/MeCN, 2:1 v/v) on a RP-C18 bonded-phase adsorbent to yield
the compounds 1, 2, and 3 (112, 115, and 108mg, respectively), which
were homogeneous after TLC (EtOAc/n-hexane, 1:19 v/v) and RP-C18
HPLC (MeCN/MeOH, 1:2 v/v).
2.4. Spectroscopic analysis
2.4.1. 3-(Hept-36-enyloxy)-2,3,4,4a,5,6,6a,12,12a,12b-decahydro-
4,6a,12a,12b-tetramethyl-1H-benzo[a] xanthene-4,10,12-triol (1)
Pale yellow oil; [α]D25 + 58.9 (c 0.1, CH3OH); UVMeOH λmax (log ε): 
278 (3.44) nm; TLC (Si-GF254 15 mm; EtOAc/n-hexane, 1:19 v/v) Rf: 
0.38; Rt (HPLC-RP-C18, MeCN/MeOH, 1:2 v/v): 3.241 min (Fig. S1); 
FTIR thin film (νmax in cm−1; bending δ, stretching ν, rocking ρ): 3420 
(O-Hν), 3029 (C-Hν (aromatic)), 2855 (C-Hν), 1625 (C=Cν), 1559 (C=Cδ 
(aromatic)), 1460 (C-Hδ), 1373 (C-Hρ), 1112, 1076 (-C-O-Cν), 856 (C-Hδ 
(aromatic)), 724 (C-Hδ) (Fig. S2); 1H NMR, 13C NMR, DEPT, COSY, HSQC, 
HMBC and NOESY data (Table 1, S1, Figs. S3–S9); EI-MS m/z calcd. for 
C28H42O5 458.3032, found 458.3037 [M]+ (∆ = 1.0 ppm) (Figs. 
S10–S11).
2.4.2. 13-[[2-(Hexyloxy)-2,5,5,8a-tetramethyldecahydro-1-naphthalenyl]
(methoxy)methyl]benzenol (2)
Yellowish oil; [α]D25 + 53.2 (c 0.1, CH3OH); UVMeOH λmax (log ε): 
281 (3.82) nm; TLC (Si-GF254 15 mm; EtOAc/n-hexane, 1:19 v/v) Rf: 
0.40; Rt (HPLC-RP-C18, MeCN/MeOH, 1:2 v/v): 3.811 min (Fig. S12); 
FTIR thin film (νmax, cm−1): 3402 (O-Hν), 3028 ( C-Hν ( aromatic)), 2923, 
2855 (C-Hν), 1634 (C=Cν), 1550 (C=Cδ (aromatic)), 1540 (C=Cν), 1459, 
1372 (C-Hδ), 1239, 1070 (C-Cν), 1120, 1070 (-C-O-Cν), 850 (C-Hδ (aro-
matic)), 723 (=C-Hδ) (Fig. S13); 1H NMR, 13C NMR, DEPT, COSY, HSQC, 
HMBC and NOESY data (Table 1, S1, Figs. S14–S20); EI-MS m/z calcd. 
For C28H46O3 430.3447, found 430.3452 [M]+ (∆ = 1.2 ppm) (Figs. 
S21–S22).
2.4.3. 1-Butoxy-4,4,11b,11c-tetramethyl-1,2,3,3a,4,5,6,6a,11b,11c-
decahydrobenzo[kl]xanthen-10-ol (3)
Yellowish oil; [α]D25 + 55.6 (c 0.1, CH3OH); UVMeOH λmax (log ε): 
283 (4.97) nm; TLC (Si-GF254 15 mm; EtOAc/n-hexane, 1:19 v/v) Rf: 
0.43; Rt (HPLC-RP-C18, MeCN/MeOH, 1:2 v/v): 4.204 min (Fig. S23); 
FTIR thin film (νmax, cm−1): 3412 (O-Hν), 3026 ( C-Hν ( aromatic)), 2921, 
2854 (C-Hν), 1638 (C=Cν), 1560 (C=Cδ (aromatic)), 1574, 1542 (C=Cν), 
1466, 1417 (C-Hδ), 1115, 1043 (-C-O-Cν), 876, 854 (C-Hδ (aromatic)), 721 
(=C-Hδ) (Fig. S24); 1H NMR, 13C NMR, DEPT, COSY, HSQC, HMBC and 
NOESY data (Table 1, S2, Figs. S25–S31); EI-MS m/z calcd. For 
C24H36O3 372.2664, found 372.2669 [M]+ (Δ = 1.3 ppm) (Figs. S32–
S33).
2.5. Antioxidant and anti-inflammatory activities
Antioxidant properties of the studied sesquiterpenes were analysed
by DPPH and ABTS+ radical quenching assays [11]. Anti-inflammatory
activities were evaluated by the inhibitory potentials of the titled
compounds against pro-inflammatory cyclooxygenases (COX-1, 2) [12]
and 5-lipoxygenase (5-LOX) enzymes [13]. The results were presented
as median inhibitory concentration (IC50, mgmL−1) at which the stu-
died compounds inhibit/scavenge 50% of the enzyme/radical activities.
The structure-bioactivity relationship analyses were conducted with the
help of various molecular descriptors, such as octanol-water partition
coefficient (hydrophobic, log Pow); electronic descriptor variable (po-
larizability, Pl); and steric descriptors (molar volume, MV; parachor, P;
molar refractivity, MR) using ACD ChemSketch (ver. 12.0; Advanced
Chemistry Development, Inc., Toronto, Canada) and ChemDraw Ultra
(Cambridge Soft Corporation, USA; ver. 12.0) programs.
2.6. Molecular modelling experiments
In silico molecular modelling of the titled compounds was carried
out using AutoDock 4 software (AutoDock Tools; ver. 1.5.6). The me-
tabolites (1–3) purified from the studied organism were made through
ACD/Chem Sketch (ver. 2016.2.2, Advanced Chemistry Development,
Inc. Toronto, Canada) and converted as Molfiles (MDL) that was saved
as PDB format (Open Babel, GUI 2.4.1). The enzyme (5-LOX) X-ray
crystal structure (PDB 3V99; resolution 2.25 Å) was obtained from the
Protein Data Bank (www.pdb.org) and conformationally arranged
(Swiss-Pdb Viewer, ver. 4.1.0). The modelling analysis was carried out
using the molecular algorithm, wherein the docking algorithm was run
by Cygwin I-II. After the completion of auto docking, the atomic posi-
tion RMSD (root mean square deviation) was analysed, and the re-
sulting conformations were ranked on the basis of docking score and
binding energy. The software USCF Chimera (University of California,
San Francisco, ver. 1.11.2) was used to visualise the molecular docking
analyses.
2.7. Statistical analysis
The statistical evaluations were tabulated as triplicates with
mean ± standard deviation. Significant differences (P≤0.05) among
the means were reported using one-way ANOVA (analysis of variance;
Statistical Program for Social Sciences, USA, ver. 13.0).
3. Results and discussion
3.1. General
In recent decades, marine macroalgal metabolites were found to
constitute a considerable share of bioactive compounds of unique
structural characteristics and valuable pharmacological properties.
Among the macroalgal metabolites, sesquiterpene quinols with rear-
ranged drimane frameworks were prominent category of marine nat-
ural products [14] with a broad spectrum of pharmacological proper-
ties, such as anti-inflammatory and antioxidant activities [15].
Structural characterisation of the drimane sesquiterpene quinols de-
rived from red marine macroalga G. salicornia was not reported yet,
although there were several reports on the structural studies of other
sesquiterpene hydroquinones from the red macroalga [4–5]. Therefore,
the present work is attempted to characterise the sesquiterpene quinols
of drimane class of chemistries, isolated from G. salicornia and evalu-
ating their anti-oxidative and anti-inflammatory pharmacological
properties. Previous studies recognised that the sesquiterpenoid che-
mistries with a hydroquinone system have lesser redox potentials,
which were found to be directly proportional with the lipoxygenase
inhibitory properties of the compounds [16]. It has also been cited that
the redox properties along with the hydrophobicity play predominant
roles in determining the 5-LOX inhibitory activities [17]. It is note-
worthy that the sesquiterpenoid quinols isolated in the present study
have higher hydrophobic values, which may reduce the leukotriene B4
(LTB4) production and resulting inflammatory cascade.
3.2. Bio-activity-guided chromatography fractionation of the secondary
metabolites of G. salicornia
Initial chromatography-assisted fractionation of EtOAc:MeOH crude
extract of red macroalgae, G. salicornia over silica gel column resulted
in eleven fractions (TA1-TA11). The percentage yields obtained for TA3
(28% w/w) was found to be significantly greater than TA1-TA2 and TA4-
TA11 (< 15%, P < 0.05). The sub-column fraction, TA3 demonstrated
greater anti-oxidative activities against free radicals, 2,2′-azino-bis-3-
ethylbenzothiozoline-6-sulfonic acid (IC50 ABTS+ 0.6–1.0 mgmL−1)
and 1,1-diphenyl-2-picrylhydrazyl (IC50 DPPH 0.6–0.8mgmL−1) than
those exhibited by other fractions (IC50 > 1.20mgmL−1). Potential
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inhibitory activities towards 5-LOX and COX-2 were characterised by
the sub-fraction, TA3 (IC50 < 0.28mgmL−1), whereas the inhibition
potentials of TA1-TA2 and TA4-TA11 were significantly lesser
(IC50 > 0.6mgmL−1, P < 0.05). Accordingly, the fraction TA3 was
selected for repetitive fractionation by reverse-phase preparative HPLC
to yield purified bioactive secondary metabolites.
3.3. Spectroscopic characterisation
The search for potent pro-inflammatory 5-LOX enzyme inhibitors
from an organic solvent extract (EtOAc/MeOH) of marine macroalga,
G. salicornia yielded three unreported drimane sesquiterpene quinols
(1–3) (Fig. 1). The comprehensive structural elucidations of these stu-
died compounds were performed by using integrated spectroscopy
(mass, 1D and 2D NMR) and previous reports of literature [18–19].
3.3.1. 3-(Hept-36-enyloxy)-2,3,4,4a,5,6,6a,12,12a,12b-decahydro-
4,6a,12a,12b-tetramethyl-1H-benzo[a] xanthene-4,10,12-triol (1)
Repeated column chromatographic fractionation of G. salicornia
yielded drimane sesquiterpene quinol, 1 that was characterised as 3-
(hept-36-enyloxy)-2,3,4,4a,5,6,6a,12,12a,12b-decahydro-4,6a,12a,12b-
tetramethyl-1H-benzo[a]xanthene-4,10,12-triol. The mass spectro-
scopic experiment displayed its molecular ion peak at m/z 458, which
corroborated its molecular formula of C28H42O5. It showed eight indices
of hydrogen deficiencies associated with one each of olefinic bond and
benzene along with three rings, which were confirmed by NMR ana-
lyses (Table 1, S1). The FTIR absorption peaks of 1 at 3420, 856/1559
and 1112–1076 cm−1 indicated the occurrences of hydroxyl, C-H aro-
matic, C=C aromatic and ether functionalities, respectively. The 1H
NMR spectrum of 1 showed singlet signals for tertiary methyls at δH
1.42, 1.15, 0.88 and 0.83, which suggested the tetra-methyl substitu-
tion in 1. The 1H NMR spectrum indicated the presence of six de-
shielded protons at δH 5.82, 5.01, 4.94, 6.81, 6.61 and 6.51, which
might be associated with the olefinic and aromatic groups. The 13C
NMR along with DEPT135 spectra displayed 28 signals comprised of four
methyls (δC 23.9, 22.6, 14.1, 19.6), nine sp3 methylenes (δC 37.0, 24.7,
21.7, 33.4, 71.1, 31.9, 26.7, 29.6, 33.8), one sp2 methylene (δC 114.0),
four sp2 methine (δC 139.2, 119.0, 119.1, 115.2), three sp3 methines (δC
84.6, 58.7, 65.5) and seven non-protonated carbons (δC 73.9, 81.6,
51.0, 42.8, 126.3, 146.5, 140.9). The COSY spectrum of 1 represented
the occurrence of two individual spin systems: I δH (1.23)-(1.56)-(2.80)
and II δH (1.53)-(1.73)-(1.37), which were assigned from H-1 to H-3
and H-4 to H-6, respectively (Fig. 2A). These spin systems were further
connected by HMBC correlations from CH2-1 (δH 1.23) to C-12b (δC
42.8); CH-3 (δH 2.80) to C-4 (δC 73.9); CH-4a (δH 1.53) to C-4 (δC 73.9)
and CH2-6 (δH 1.70) to C-6a (δC 81.6), C-12a (δC 51.0), which supported
the bicyclic framework of 1 (Fig. 2A). Other HMBCs from CH3-14 (δH
1.42) to C-6a (δC 81.6); CH3-13 (δH 1.15) to C-4 (δC 73.9); CH3-15 (δH
0.88) to C-12a (δC 51.0) and CH3-16 (δH 0.83) to C-12b (δC 42.8)
confirmed the attachment of four singlet methyl carbons at C-6a, C-4, C-
12a, and C-12b, respectively, which appropriately corroborated the
presence of bicyclic framework of drimane sesquiterpenoid. The three
protons at δH 6.5–6.8 of 1 showed that aromatic ring might be trisub-
stituted, and the COSY correlations from δH (6.81)-(6.61) (H-8 to H-9)
along with singlet aromatic signal at δH 6.51 suggested that it might be
in the meta-para fused relationship with the basic framework of 1. The
greatly deshielded quaternary carbon at δC 146.5 was related to the
hydroxyl attached to the benzene ring. The highly deshielded singlet
proton at δH 4.68 exhibited HMBCs to C-12a (δC 51.0) of the drimane
sesquiterpenoid and to C-11a (δC 126.3) of the aromatic ring. The de-
shielded signals at C-3 (δC 84.6), C-4 (δC 73.9), C-6a (δC 81.6), C-10 (δC
140.9) and C-12 (δC 65.5) in the 13C NMR spectrum and absence of any
carbonyl absorbances in IR spectrum of 1 were accounted for oxyge-
nated functional groups, such as hydroxyl or ether. The greatly de-
shielded oxygenated quaternary carbon at δC 146.5 revealed that one of
the oxygen atoms might form an ether bridge from drimane
sesquiterpenoid to the aromatic ring system. These attributions re-
cognised the occurrence of a quinol moiety in 1, and suggested the
association of drimane-quinol framework (benzo-xanthene) of sesqui-
terpene 1. These spectroscopic assignments suggested the resemblance
of compound 1 with the previously reported drimane sesquiterpene
quinols and quinones [18–23]. The greatly deshielded olefinic groups at
δH 5.01, 4.94/δC 114.0 and δH 5.82/δC 139.2 with higher coupling
constants (J=12.2–16.7) suggested the possibilities of a terminal
monosubstituted vinylic group at -CH(36)= CH2(37). The spin system
from δH (3.69)-(1.55)-(1.21)-(1.33)-(2.04)-(5.82)-(4.94) suggested the
linear arrangement of protons from H-31 to H-37, which was identified
as hept-36-enyloxy chain. The strong HMBC coupling from CH2-31 (δH
3.69) to C-3 (δC 84.6) appropriately delineated the attachment of hept-
36-enyloxy at C-3 (δC 84.6) of the substituted drimane framework as an
ether linkage. Relative stereochemistries of chiral centers at C-3, C-4, C-
4a, C-6a, C-12a, C-12, and C-12b in 1 were assigned by NOESY ex-
periments (Fig. 2B). The NOESY correlations between δH 1.96 (Hβ-2)/
2.80 (H-3)/1.45 (Hβ-5); δH 1.15 (H-13)/0.83 (H-16)/1.45 (Hβ-5)/0.88
(H-15)/1.42 (H-14) attributed that these protons were coordinated in
the same plane of reference, and hence, were arbitrarily assigned as β-
oriented. Deshielded proton signals at δH 4.68 (H-12)/1.70 (Hα-6)/1.53
(H-4a) were found to be opposite to the β-oriented protons, and thus
were arbitrarily attributed as α-aligned. The structural assignments of 1
were corroborated by mass spectral experiment, wherein the molecular
ion peak at m/z 458 (1a) experienced the removal of a methyl-radical
and H2O to result C27H39O4%+ (1b) with m/z 427. The elimination of
C4H8% and H2O from 1b could result in the formation of C23H29O3+
with m/z 353 (1c). The fragment, 1c appeared to undergo further series
of fragmentation to yield the mass fragments at m/z 77, 220, 189, 146,
and 108. The base peak of the compound 1 was found at m/z 77, which
was found to correspond to the phenyl cation (C6H5+) (Fig. S11). The
1D and 2D NMR assignments along with mass spectroscopic data un-
ambiguously constructed the structure of the drimane sesquiterpene
with substituted 1H-benzo[a]xanthene-4,10,12-triol moiety (1).
3.3.2. 13-[[2-(Hexyloxy)-2,5,5,8a-tetramethyldecahydro-1-naphthalenyl]
(methoxy)methyl]benzenol (2)
Repeated silica-gel column fractionation of the solvent extract of G. 
salicornia yielded substituted drimane derivative, 2 that was char-
acterised as 13-[[2-(hexyloxy)-2,5,5,8a-tetramethyldecahydro-1-naph-
thalenyl](methoxy)methyl]benzenol. The molecular formula of 2 was 
inferred as C28H46O3, using integrated mass (m/z 430) and compre-
hensive NMR data (Table 1, S1). Its six degrees of unsaturation was 
corroborated for two cyclic rings and aromatic ring. The FTIR absorp-
tion peaks at 3402, 3028/850/1550 and 1120–1070 cm−1 suggested the 
probable presence of hydroxyl, aromatic and ether functionalities, 
respectively in the compound 2. The 1H NMR spectrum of the studied 
compound showed singlet signals for four tertiary methyls at δH 1.22, 
1.03, 1.00 and 1.02, which suggested the presence of tetramethyl 
groups. The spectrum also indicated the presence of four aromatic hy-
drogens at δH 6.35, 7.08, 6.23 and 6.28. The deshielded protons at δH 
3.69 and 3.37 might be associated with an oxygenated functionality, 
such as ether linkage. The 13C NMR along with DEPT135 spectra of 2 
displayed the presence of 28 carbon signals, including six methyls (δC 
22.5, 29.7, 29.3, 16.3, 14.1, 58.9), ten sp3 methylenes (δC 39.3, 19.3, 
45.0, 19.6, 39.4, 65.0, 31.9, 25.6, 33.7, 22.7), three sp3 methines (δC 
55.0, 65.7, 82.7), four sp2 methines (δC 123.7, 128.4, 113.1, 113.0), 
and five q uaternary c arbons ( δC 3 2.7, 7 2.4, 3 7.2, 1 44.0, 1 54.3). The 
COSY spectrum of 2 suggested the presence of spin systems, such as δH 
(1.51)-(1.75)-(1.50) and δH (0.88)-(1.42)-(1.77), which correspond to 
the partial structure of bicyclic ring from H-8/H-7/H-6 and H-4a/H-4/
H-3, respectively (Fig. 2C). The HMBCs from CH3-9 (δH 1.22) to C-2 (δC 
72.4); CH3-10 (δH 1.03) and CH3-11 (δH1.00) to C-5 (δC 32.7); and from 
CH3-12 (δH 1.02) to C-8a (δC 37.2) demonstrated the methyl substitu-
tions at C-2, C-5 and C-8a. The NMR spectroscopic investigations along 
with previous studies suggested the basic skeleton of 2 as a drimane
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sesquiterpenoid [22–23]. The aromatic region of the proton spectrum
exhibited an integral of four in which one singlet, two doublets and one
triplet were accounted. The greatly deshielded carbon signal at δC 154.3
(assigned as C-1′) supported the presence of hydroxylated functionality
at that position. The spin systems among the aromatic protons from δH
(6.35)-(7.08)-(6.23) {H-4′/H-5′H-6′} suggested the occurrence of 1,3-
disubstituted aromatic ring. The HMBC correlations from CH-4′ (δH
6.35) to C-3′ (δC 144.0); from CH-6′ (δH 6.23) to C-1′ (δC 154.3) and CH-
2′ (δH 6.28) to C-3′ (δC 144.0), C-1′ (δC 154.3) attributed the possibi-
lities of hydroxylated aromatic ring system. The strong HMBCs from δH
4.39 (H-13) to δC 144.0 (C-3′) of benzene ring supported the attachment
of hydroxybenzene to methine of the driamane skeleton located at C-13
position. Other spin systems from δH (3.69)-(1.53)-(1.31)-(1.34)-(1.33)-
(0.94) assigned the continuous linear chain of hexane from H-21 to H-26
in which H-21 was found to be oxygenated, hence named as hexyloxy
chain. The latter was linked at C-2 of the basic drimane skeleton as it
recorded strong HMBCs from CH-21 (δH 3.69) to C-2 (δC 72.4). On the
basis of 1D and 2D experimental data, the basic core of compound 2
strongly resembled to the quinol associated drimane sesquiterpene
system [20]. Relative stereochemistries of the chiral centers at C-1, C-2,
C-4a, C-5, C-8a and C-13 in 2 were assigned by NOESY experiments
(Fig. 2D). The NOESY spectrum demonstrated that the protons δH 1.02
(H-12)/1.42 (Hβ-4)/1.22 (H-9) and δH 1.42 (Hβ-4)/1.03 (H-10) dis-
played similar spatial correlations, and these protons were located in
identical molecular reference plane, thus arbitrarily assigned as β-or-
iented. The NOESY correlations at δH 4.39 (H-13)/1.00 (H-11)/0.88 (H-
4a), 1.17 (Hα-6), 1.92 (H-1) were found to be trans oriented to the β-
protons, and therefore, assigned as α-protons. The structure elucidation
of 2 was corroborated by the mass spectral experiment, wherein the
molecular ion peak at m/z 430 (2a) experienced the removal of a me-
thyl-radical and H2O to yield C27H43O2%+ (2b) with m/z 399. The
elimination of CH3O% and %CH3 from 2b resulted in the formation of
C25H37O%+ with m/z 353 (2c). The fragment at m/z 309 (2d) under-
went further series of fragmentation to result m/z 77 (2j) as the base
peak, which was found to correspond the phenyl radical (C6H5%) (Fig.
S22). The NMR assignments along with mass spectroscopic data un-
ambiguously constructed the structure of drimane sesquiterpene with
substituted [(naphthalenyl)(methoxy)methyl]benzenol framework of
the studied compound (2).
Fig. 2. 1H-1H COSY (bold face bonds), selected HMBCs (double-barbed arrows), and NOE (coloured arrows) correlations of 3-(hept-36-enyloxy)-
2,3,4,4a,5,6,6a,12,12a,12b-decahydro-4,6a,12a,12b-tetramethyl-1H-benzo[a]xanthene-4,10,12-triol (1) (A–B), 13-[[2-(hexyloxy)-2,5,5,8a-tetramethyldecahydro-1-
naphthalenyl](methoxy)methyl]benzenol (2) (C-D) and 1-butoxy-4,4,11b,11c-tetramethyl-1,2,3,3a,4,5,6,6a,11b,11c-decahydrobenzo[kl]xanthen-10-ol (3) (E–F)
isolated from G. salicornia. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
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3.3.3. 1-Butoxy-4,4,11b,11c-tetramethyl-1,2,3,3a,4,5,6,6a,11b,11c-
decahydrobenzo[kl]xanthen-10-ol (3)
Repeated chromatographic fractionation of the organic solvent ex-
tract of G. salicornia resulted to substituted drimane derivative, 3 that
was characterised as 1-butoxy-4,4,11b,11c-tetramethyl-1,2,3,3a,
4,5,6,6a,11b,11c-decahydrobenzo[kl]xanthen-10-ol. The molecular
formula of 3 was inferred as C24H36O3, using integrated mass (m/z 372)
and NMR experiments (Table 1, S2). Its seven degrees of unsaturations
were corroborated to three ring systems and one aromatic ring. The
FTIR absorption peaks at 3412, 3026/854/1560 and 1115–1043 cm−1
assigned the occurrences of hydroxyl, aromatic and ether functional-
ities, respectively. The 1H NMR showed signals of four tertiary methyls
at δH 1.37, 1.00, 0.98 and 1.15, which were typical of the drimane
sesquiterpene framework [20]. The spectrum also indicated the pre-
sence of three aromatic hydrogens at δH 6.31, 6.26, and 6.20. In ad-
dition, a methyl triplet at δH 0.88 suggested the occurrence of terminal
methyl substitution. The 13C NMR along with DEPT135 spectra of 3
displayed the presence of 24 carbon signals, including five methyls (δC
22.6, 28.8, 29.3, 12.8, 14.1), seven sp3 methylenes (δC 24.4, 42.2, 22.7,
29.6, 74.6, 31.9, 18.7), three each of sp3 methines (δC 81.0, 78.1, 52.3)
and sp2 methines (δC 115.1, 118.1, 121.7) along with six quaternary
carbons (δC 37.2, 45.4, 39.3, 128.7, 139.9, 155.9). The COSY spectrum
of 3 assigned the occurrences of four individual spin units, I: δH (3.20)-
(1.84)-(1.51) and II: δH (1.21)-(1.57)-(1.81)-(3.88), which were ac-
counted for the partial structure of the bicyclic ring; III: δH (6.26)-(6.20)
corresponding to the aromatic ring part, and IV: δH (3.44)-(1.50)-
(1.43)-(0.88) was accounted for the presence of butoxy chain (Fig. 2E).
The HMBC correlations from CH-6a (δH 3.20) to C-11c (δC 39.3); from
CH2-5 (δH 1.20) and CH-3a (δH 1.21) to C-4 (δC 37.2); from CH-3a (δH
1.21) to C-11c (δC 39.3) and from CH-1 (δH 3.88) to C-11b (δC 45.4)
appropriately suggested the complete structure of bicyclic drimane
skeleton (Fig. 2E). Other key HMBCs were assigned from CH3-12 (δH
1.00) and CH3-13 (δH 0.98) to C-4 (δC 37.2); from CH3-15 (δH 1.15) to
C-11c (δC 39.3) and from CH3-14 (δH 1.37) to C-11b (δC 45.4), which
attributed the methyl substitutions at C-4, C-11c and C-11b. The greater
deshielded signal at δC 155.9 was found to be due to the aromatic hy-
droxyl, whereas the aromatic proton integral of three suggested the
possibility of trisubstituted aromatic ring in 3. Other HMBCs from CH-
11 (δH 6.31) to C-11a (δC 128.7), C-9 (δC 121.7), C-10 (δC 155.9) and
from CH-8 (δH 6.26) to C-7a (δC 139.9) attributed to the occurrence of
hydroxybenzene ring functionality. The strong HMBC correlation from
CH-6a (δH 3.20) to C-7a (δC 139.9) supported the attachment of dri-
mane skeleton to the aromatic ring through an ether linkage. The bu-
toxy side chain was attached at C-1 of the quinol associated drimane
sesquiterpene, and this attribution was confirmed through strong
HMBCs from CH-1 (δH 3.88) to C-11 (δC 74.6). The compound 3 was
structurally related to the previously reported quinol fused drimane
sesquiterpenes [18,20] and compound 1 except the dissimilarities
perceived in the NMR signals due to the ether substitutions of the tet-
racyclic core, and also in the position and number of the methyl func-
tionalities. The relative stereochemistries of the chiral centers at C-1, C-
3a, C-4, C-6a, C-11b, and C-11c in 3 were designated through NOESY
experiments (Fig. 2F). The NOESY correlations between δH 3.20 (H-6a)/
1.15 (H-15)/1.37 (H-14)/1.00 (H-12) were found to be in the identical
plane of symmetry, and therefore, were arbitrarily attributed as β-faced
protons. Similarly, NOE correlations were exhibited by the proton at δH
0.98 (H-13) with those at δH 3.88 (H-1) and 1.21 (H-3a). These were
found to be situated at the opposite plane of the β-protons, and thus,
were assigned as α-disposed. The structural elucidation of 3 was cor-
roborated by the mass spectral experiment, wherein the molecular ion
peak at m/z 372 (3a) experienced the elimination of a C2H5% radical
and H2O to result in the mass fragment C22H29O2+ (3b) with m/z 325.
The removal of C2H5O% from the latter could result in the formation of
C20H24O%+ with m/z 280 (3c). The fragment (3d) with m/z 258 ap-
peared to undergo further series of fragmentation to yield m/z 94,
which was considered as the base peak (Fig. S33).
3.4. Bioactivities of the drimane sesquiterpenoids isolated from G. salicornia
The in vitro radical scavenging assays by DPPH and ABTS+ radicals
were used to ascertain the antioxidant properties of the studied drimane
sesquiterpene derivatives (Table 2). The studied compound, 1 bearing
substituted 1H-benzo[a]xanthene-4,10,12-triol moiety exhibited
greater radical scavenging activities (IC50 DPPH 1.33mM; IC50 ABTS+
1.57mM), when compared to the standard α-tocopherol (IC50 DPPH
1.46mM; IC50 ABTS+ 1.70mM). There were previous reports on DPPH
Table 2
In vitro bioactive potentials (antioxidant and anti-inflammatory) of compounds 1–3 and commercially available references along with their molecular descriptors
(electronic, steric and hydrophobic).
Compounds Antioxidant activities
(IC50, mM)
Anti-inflammatory activities
{Inhibitory activities against pro-inflammatory enzymes}
(IC50, mM)
Selectivity index
DPPH scavenging ABTS+ scavenging COX-1 inhibitory COX-2 inhibitory 5-LOX inhibitory
1 1.33 ± 0.01a 1.57 ± 0.02a 1.54 ± 0.02a 1.35 ± 0.01a 1.72 ± 0.01a 1.14 ± 0.02a
2 1.51 ± 0.01b 1.88 ± 0.02b 1.72 ± 0.03b 1.56 ± 0.01b 1.90 ± 0.01b 1.10 ± 0.01b
3 1.85 ± 0.02c 1.96 ± 0.01c 2.09 ± 0.01c 1.91 ± 0.02c 2.55 ± 0.01c 1.09 ± 0.02b
Standard 1.46 ± 0.04dT 1.70 ± 0.05dT 0.19 ± 0.00dI 0.44 ± 0.02dI 4.51 ± 0.11dI 0.44 ± 0.01cI
Molecular descriptors#
Compounds Electronic Steric Hydrophobic
Pl (×10−24 cm3) tPSA P (cm3) MV (cm3mol−1) MR (cm3mol−1) Log POW
1 51.65 79.15 1053.00 394.20 130.30 4.99
2 51.34 38.69 1060.80 423.30 129.50 7.13
3 43.18 38.69 873.20 339.50 108.93 5.64
The antioxidant and anti-diabetic activities were expressed as IC50 values (mM).
a–dColumn-wise values with different superscripts of this type indicate significant difference (P < 0.05), which implied for the statistical evaluation of the results.
MV, molar volume; P, parachor; MR, molar refractivity.
log P, logarithmic scale of the octanol-water partition coefficient; Pl, polarizability; tPSA, topological polar surface area.
#The structure-activity relationship analysis was carried out by using different molecular descriptors of the purified compounds as described in the text.
TSuperscript of this type depicts α-tocopherol. I Superscript of this type depict ibuprofen.
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radical scavenging activities of drimane sesquiterpenoids [21] that
corroborated the antioxidant activity of terpenoids sketched in the
current work. The aromatic, hydroxyls and ether functionalities in the
studied compounds could be incorporated in the process of delocali-
zation of electron in the radical scavenging mechanism of the DPPH
radical, which might be one of the predominant reasons for potential
antioxidant properties of the studied compounds (1–3). There were
previous reports on the antioxidant properties of the metabolites with
conjugated olefinic, aromatic, and hydroxyl functionalities [24].
Among the isolated compounds, the one with substituted 1H-benzo[a]
xanthene-4,10,12-triol (1) showed greater ABTS+ and DPPH radical
activities (IC50 1.57 and 1.33mM, respectively) over those exhibited by
compounds 2 and 3 (IC50 1.88–1.96 and 1.51–1.85mM, respectively).
The in vitro anti-inflammatory potential of the isolated compounds were
evaluated by their inhibition potential towards pro-inflammatory COX-
1, 2 and 5-LOX enzymes. Among the studied compounds, 1 showed
greater COX-2 and 5-LOX inhibitory activities (IC50 1.35 and 1.72mM,
respectively) over those displayed by 2–3 (COX-2 IC50 1.56–1.91mM
and 5-LOX IC50 1.90–2.55mM, respectively) (Table 2).
The target bioactivities of the studied metabolites were corrobo-
rated by different physico-chemical parameters describing their struc-
tural features. It is pertinent to note that the electronic parameters of
the drimane derivative bearing substituted 1H-benzo[a]xanthene-
4,10,12-triol moiety (1) was higher (polarizability, Pl
~51.65× 10−24 cm3, tPSA, topological polar surface area, 79.15) than
those recorded by the compounds 2 and 3 (Pl 51.34
–43.18× 10−24 cm3, tPSA, 38.69), which could be related with the
greater pro-inflammatory inhibitory activities of the former (Table 2). It
was apparent that the compound 2 was bulkier than 1, as determined
by the lower steric factors of the latter (molar refractivity, MR
130.30 cm3mol−1, molar volume, MV 394.20 cm3mol−1, and P
1053.00 cm3). The increased bulkiness of 2 might restrict the metabo-
lite to efficiently interact with the active site of enzyme residues, re-
sulting in its lesser inhibitory activity towards pro-inflammatory en-
zymes in comparison with compound 1. It was also likely that that a
medium hydrophobicity (logarithmic value of octanol-water coeffi-
cient, log Pow 4.99) of compound (1) predominantly contributed to-
wards the comparatively higher radical quenching and pro-in-
flammatory enzyme inhibitory activities than those displayed by its
drimane quinol analogues (2–3). The compounds 2 and 3 were found to
record higher (log Pow 7.13 and 5.64, respectively) than the desired
lipophilicity (log Pow 2–5), which might explain their lesser electronic
interactions resulting in lower antioxidant and anti-inflammatory
bioactivities [25].
The studied drimane sesquiterpene quinols, 1–3 were deduced to
contain hydroxyphenyl functionality linked to the drimane framework.
The hydroxyphenyl part of the studied compounds might be involved in
the resonance stabilization through the transfer of proton from hy-
droxyl to DPPH radical via hydrogen atom transfer mechanism (HAT).
The three titled compounds enclosed similar type of functionalities,
even though the numbers of antioxidative reaction centers were found
to differ. The greater number of electron rich reaction centers (three
hydroxyls, one alkene, and phenyl) in 1 over those possessed by com-
pounds 2–3 (one each of hydroxyl phenyl functionalities) in combina-
tion with the optimum hydrophobicity (log Pow < 5) factors, might
occupy prominent roles in the greater bioactive potential of the former.
The anti-inflammatory potentials of the drimane sesquiterpene quinols
were reported in a previous report of literature [15]. A previous study
on drimane based sesquiterpene quinol, dysiquinol D proposed that the
compound bearing an ether linkage between C-8 and C-17 positions
exhibited greater anti-inflammatory potential than dysiquinols A-C
possessing ether bridge between C-1 and C-17 [19]. Herein, the com-
pound 1 bearing substituted 1H-benzo[a]xanthene-4,10,12-triol moiety
was structurally comparable with dysiquinol D and enclosed ether
bridge in the identical position as in dysiquinol D attributing the greater
bioactive potential of 1 than those exhibited by compounds 2 (no ether
linkage) and 3 (comparable to dysiquinol A-C skeleton).
3.5. In silico molecular modelling studies of the drimane derivatives
The studied compounds were subjected to in silico molecular
docking analysis against pro-inflammatory 5-LOX and the results were
evaluated by their RMSD data. The molecular docking parameters, such
as binding energy, docking score, inhibition constant, hydrogen
bonding interactions, torsional free energy and intermolecular energy
between the active sites of 5-LOX and the ligands were documented in
Table 3. The grid box of potential binding site was assigned as
x=54.00 y=44, z= 42. Among the studied compounds, substituted
1H-benzo[a]xanthene-4,10,12-triol (1), on molecular docking analysis
with 5-LOX exhibited two hydrogen bond interaction with amino acyl
residues Lys441 and Arg438 in the enzyme active site with molecular
distances of 3.370 and 3.030 Å, respectively (Fig. 3). Among the re-
maining drimane analogues, compounds 2 and 3 showed one hydrogen
bonded interactions with the amino acyl residues Gln150 and Lys441
with molecular distances of 2.790 Å and 2.915 Å, respectively. The
metabolite 1 exhibited greater number of hydrogen bond interactions
with amino acyl residues than those recorded by compounds 2 and 3.
These results could be supported by the higher in vitro anti-in-
flammatory activity of 1 over those displayed by 2 and 3. The com-
parison of molecular docking parameters appropriately suggested that
compound 1 bearing substituted 1H-benzo[a]xanthene-4,10,12-triol
moiety exhibited closer molecular interactions towards 5-LOX with
least binding energy (−12.30 kcal mol−1) and docking score
(−12.96 kcal mol−1), which were corroborated with their greater in-
hibition of 5-LOX than those exhibited by its drimane quinol analogues
(compounds 2 and 3).
3.6. Putative biosynthetic origin of the drimane sesquiterpenoid quinol
derivatives (1–3)
The drimane sesquiterpenoids enclosing quinol functionalities were
largely found in sponges [19–20] and marine macroalgae [4,26]. Avarol
was found to be the first and important representative of the sesquiterpene
hydroquinones isolated from a marine sponge, Dysidea avara [27]. The
titled compounds featured a sesquiterpene-based rearranged drimane
skeleton substituted with quinol moiety, and these chemistries of organic
compounds were characterised by their potent therapeutic effects.
Therefore, it was of interest to investigate the biosynthetic mechanisms
leading to the formation of drimane sesquiterpenoid quinols possessing
diverse functional chemistries. The putative biosynthetic pathway leading
Table 3
The binding energy, docking score, inhibition constant, intermolecular energy and torsional free energy between the ligands (compounds 1–3) and the active sites of
5-lipoxygenase.
Ligands Binding energya
(kcal mol−1)
Docking scorea
(kcal mol−1)
Inhibition
constanta, Ki (nM)
Intermolecular energya
(kcal mol−1)
Torsional free energya
(kcal mol−1)
Hydrogen bonded
residues
Distance from hydrogen
bonded residue (Å)
1 −12.30 −12.96 1.23 −13.14 1.79 Lys441, Arg438 3.370, 3.030
2 −9.97 −11.10 48.94 −11.10 1.19 Gln150 2.790
3 −9.71 −10.60 76.63 −10.75 1.19 Lys441 2.915
a Values were evaluated from the calculations based on the energy minimization.
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Fig. 3. Closer view of molecular binding interactions of the drimane sesquiterpene quinols in the catalytic site of (A–C) 5-lipoxygenase (5-LOX) as deduced from the
molecular docking simulation experiment. The molecular docking analysis of ligands (studied sesquiterpene analogues 1–3) and pro-inflammatory 5-LOX showed
two hydrogen bonds (displayed as red and blue-coloured lines with amino acyl residues of Lys441 and Arg438 with bond distances of 3.370 and 3.030 Å, respectively)
in the active binding site. The compounds 2 and 3 showed one hydrogen bonded interactions with amino acyl residues Gln150 and Lys441 with molecular distances of
2.790 Å and 2.915 Å, respectively. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
Fig. 4. Schematic representation of the putative biosynthetic pathways of drimane sesquiterpene quinols (1–3) isolated from G. salicornia.
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to drimane sesquiterpenoid quinols involves cyclization of farnesyl di-
phosphate (FPP) resulting from an electrophilic attack by a H+ ion on the
olefinic bond located at the apical position of FPP, and a major carboca-
tionic rearrangement to form a bicyclic framework of drimane (Fig. 4). It
was found that the drimane class of terpenoids inherit the structural
characteristics of the fused bicyclic ring system, and was recognised as the
“missing-link” between sesquiterpenoid and di-/triterpenoid class of che-
mistries. Further substitutions of diphosphate group by shikimate-origin
quinols were reported to form secondary metabolites of drimane class of
sesquiterpenoids [28]. Previous reports of literature recognised the en-
zyme-mediated elimination of pyrophosphate group of drimane pyr-
ophosphate (D) yielding a carbocation [29–30]. The electrophilic attack of
the carbocation (E) on the semiquinone (derived from the shikimate-de-
rived hydroquinone) appeared to form a methylene-bridge (-CH2-) be-
tween E and E1 (hydroquinone) resulting in the formation of an inter-
mediate 6-((octahydro-1,1,4a,6-tetramethylnaphthalen-5-yl)methyl)-4-
hydroxycyclohexa-2,4-dienone (F). An intra-molecular cyclization to form
a substituted 2H-benzo[a]xanthen-10-ol scaffold (H) followed by S-ade-
nosyl methionine (SAM)-mediated methyl transfer reaction (catalysed by
methyl transferase) yielded decahydro-4,4,6a,12a,12b-pentamethyl-2H-
benzo[a]xanthen-10-ol (I). The hydroxylation at C-3 and C-4 of the dec-
ahydro-1,4a-dimethylnaphthalene-1,2-diol moiety were due to the cyt-
P450 (monooxygenase)-catalysed hydroxylation reaction, and therefore, it
was reasonable to attribute the presence of a methoxy group (-OCH3) at C-
12 position of the compound 1, appeared to originate by the sequential
hydroxylation and methyl transfer reactions (Fig. 4). Further, the chain
elongation of the C-3 hydroxyl group appeared to result in the formation
of compound 1. Unlike, compound 1, there appeared to be no in-
tramolecular cyclization, where the hydroxyl group in biosynthetic inter-
mediate (G) could be originated from the hydroxyl group of the hydro-
quinone (F) part through an intramolecular rearrangement reaction. The
-CH(OH) group of 1-(hydroxy(3-hydroxyphenyl)methyl)-tetramethyl-
decahydronaphthalen-2-ol (K) might find its origin by the mono-
oxygenase-catalysed hydroxylation reaction, and therefore, it was rea-
sonable to assign the presence of the methoxy group at the C-13 position of
compound 2 by SAM-mediated methyl-transfer catalysis. Likewise, a car-
bocation intermediate formed by the release of pyrophosphate from dri-
mane pyrophosphate (D) exhibited the monooxygenase-catalysed hydro-
xylation at C-1 position of (D). It might be possible that the shikimate-
derived hydroquinone was involved to form 4-((8-(hydroxymethyl)-
4,4,7,8a-tetramethyl-octahydronaphthalen-1-yl)oxy)phenol analogue (M).
The latter appeared to undergo intramolecular rearrangement and SAM-
mediated methyl transfer reactions to yield 1,3a1,4,4-tetramethyl-hex-
ahydrobenzo[kl]xanthen-10-ol derivative (P). A hydroxymethyl group at
C-1 position might originate by a hydroxylation reaction catalysed by Cyt
P450-dependent monooxygenase, and further side chain elongation re-
sulted in compound 3 (Fig. 4). The proposed biosynthetic pathway
through enzyme-mediated cascade furthermore validated the structural
attributions of the studied drimane sesquiterpene quinols.
4. Conclusions
The organic extract of the intertidal marine macroalga, G. salicornia
was fractionated by repeated techniques of chromatography to obtain
three unprecedented drimane sesquiterpene quinol analogues. Among
the isolated compounds, the compound (1) with benzo[a]xanthene-
4,10,12-triol moiety showed greater pro-inflammatory enzyme in-
hibitory activities (IC50 1.35–1.72mM) over other studied drimane
quinol chemotypes. Positive correlations between the antioxidant and
anti-inflammatory activities were recorded, whereas the compound (1)
displayed greater oxidant scavenging potentials (IC50 1.33–1.57mM)
than that exhibited by α-tocopherol. Structure-bioactivity correlation
analysis showed that lesser hydrophobicity and steric bulk of the
compound (1) predominantly contributed towards the comparatively
greater radical quenching and pro-inflammatory enzyme inhibitory
activities than those displayed by its drimane counterparts 2–3. In silico
molecular modelling studies were performed to designate the 5-lipox-
ygenase inhibitory mechanism of the compound (1) exhibiting binding
energy of −12.30 kcal mol−1, which substantiated its potential in-
hibitory activity against the inflammatory mediators. An enzyme-
mediated biosynthetic cascade leading to the formation of drimane
sesquiterpenoid quinol derivatives was proposed. The results illustrated
the bioactive potential of the natural anti-inflammatory drimane ses-
quiterpenoid bearing benzo[a]xanthene-4,10,12-triol moiety attenu-
ating pro-inflammatory 5-LOX from marine macroalga G. salicornia.
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